You are here

  • Home
  • Archive
  • Volume 15, Issue 4
  • Recrudescence of severe polyneuropathy after receiving Pfizer-BioNTech COVID-19 vaccine in a patient with a history of eosinophilic granulomatosis with polyangiitis

Article info

Article menu

Download PDFPDF

Case Reports: Adverse drug reactions and complications
Recrudescence of severe polyneuropathy after receiving Pfizer-BioNTech COVID-19 vaccine in a patient with a history of eosinophilic granulomatosis with polyangiitis
Free

Authors

  1. Correspondence to Dr Rahul Gill; gillrahul1981@gmail.com
View Full Text

Citation

Gill R, Rizvi M, Sadiq MS, et al
Recrudescence of severe polyneuropathy after receiving Pfizer-BioNTech COVID-19 vaccine in a patient with a history of eosinophilic granulomatosis with polyangiitis
BMJ Case Reports CP 2022;15:e245749.

Publication history

  • Accepted March 29, 2022
  • First published April 29, 2022.
Online issue publication 
January 24, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Request permissions

Copyright information

© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.